Dr. Michael Scott Putman, MD

Dr. Putman practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Putman's NPI, 1235577016, was assigned on June 13, 2013. Dr. Putman graduated from University of Chicago, Pritzker School of Medicine in 2013. Dr. Putman holds Wisconsin license 72734.

Dr. Putman's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Putman's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Putman is also affiliated with Froedtert Menomonee Falls Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Putman to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Putman practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Putman's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Putman's licenses on file in 2 states: Wisconsin and Illinois.

CMS data shows 320 Medicare services from Dr. Putman across 4 procedure codes in 2024, for 100 Medicare patients. Medicare paid $18,937 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Putman in 2024. The largest group is 65 to 74, with 41 patients. 74% of them have high blood pressure, and 72% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Putman's median patient age at 65, with 67% women.

In 2024, Dr. Putman wrote 623 Medicare Part D claims for 129 patients. 74% of them were for generic drugs. CMS names the drug for 514 of them, across 15 drugs with 11 or more claims each, at $956,269 in total drug cost. In 2023, CMS named 478 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Putman for performance year 2024, reported as part of a group. Dr. Putman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Putman as offering telehealth.

Dmand AI links 79 papers to Dr. Putman, published from 2012 to 2025. 2022 was the busiest year, with 12. The most frequent topics are COVID-19, Rheumatology and Giant Cell Arteritis. Dr. Putman has published most often in Lancet Rheumatol. Dr. Putman's most frequent co-authors are Jean W. Liew, MD, Jeffrey A. Sparks, MD and Richard Gary Conway, MD.

CMS Open Payments shows 19 general payments to Dr. Putman from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Novartis Pharmaceuticals Corporation paid the most, $10,132.

Dr. Putman graduated from University of Chicago, Pritzker School of Medicine in 2013.